09.04.2020 Drägerwerk AG & Co. KGaA  DE0005550602

DGAP-Adhoc: Drägerwerk AG & Co. KGaA: Dräger with strong order entry in the first quarter


 

DGAP-Ad-hoc: Drägerwerk AG & Co. KGaA / Key word(s): Incoming Orders/Development of Sales
Drägerwerk AG & Co. KGaA: Dräger with strong order entry in the first quarter

09-Apr-2020 / 17:10 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Ad-hoc notification in accordance with Sec. 17 of the MAR

Drägerwerk AG & Co. KGaA: Dräger with strong order entry in the first quarter

Dräger's order intake in the first quarter of fiscal 2020 soared compared to the first quarter of last year in the context of the Covid-19 Pandemic. The order intake in Q1 amounted to around EUR 1,393 mn. (Q1 2019: EUR 648 mn.), 117% (net of currency effects) above the level a year ago. The demand in the medical division is currently particularly high. Orders in the medical division were around EUR 1,043 mn. (Q1 2019: EUR 376 mn.) which is an increase of around 179% (net of currency effects) compared to same period a year ago. Orders in the safety division rose by around 31% (net of currency effects) to around EUR 349 mn. (Q1 2019: EUR 271 mn.).

Net sales so far benefited only to a smaller degree from the high order intake. Net sales in the first quarter amounted to around EUR 640 mn. (Q1 2019: EUR 602 mn.) which is around 7.1 % (net of currency effects) above the level a year ago. Earnings figures for the first quarter are not available yet.

The preliminary result for the first quarter 2020 should be available for publication towards the end of next week.

Drägerwerk AG & Co. KGaA
Moislinger Allee 53-55
23558 Lübeck, Deutschland
www.draeger.com

Investor Relations:
Thomas Fischler
Tel. +49 451 882-2685
[email protected]

Corporate Communications:
Melanie Kamann
Tel. +49 451 882-3998
[email protected]

Disclaimer
This ad hoc report contains statements on the future development of Dräger Group. These forward-looking statements are based on the current expectations, presumptions, and forecasts of the Executive Board as well as the information available to date. They were compiled to the best of the company's knowledge. Dräger does not provide any warranty nor assume any responsibility for the future developments and results described above. These are dependent on a number of factors. They entail various risks and contingencies outside of the company's influence and are based on assumptions which could prove to be incorrect. Dräger does not assume any responsibility for updating the forward-looking statements contained in this report. This does not infringe any legal stipulations on the adjustment of forecasts. Please go to Investor Relations / Definitions of financial indicators at www.draeger.com for information on alternative performance measures used.


09-Apr-2020 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: Drägerwerk AG & Co. KGaA
Moislinger Allee 53-55
23542 Lübeck
Germany
Phone: +49 (0)451 882-0
Fax: +49 (0)451 882-2080
E-mail: [email protected]
Internet: www.draeger.com
ISIN: DE0005550602, DE 000 555 063 6, DE 000 555 065 1, DE 000 555 067 7, DE 000 555 071 9
WKN: 555060, 555063 Vorzüge, 555065 Genussschein A, 555067 Genussschein K, 555071 Genussschein D
Indices: SDAX, TecDAX
Listed: Regulated Market in Berlin, Dusseldorf, Frankfurt (Prime Standard), Hamburg, Hanover, Munich; Regulated Unofficial Market in Stuttgart, Tradegate Exchange
EQS News ID: 1019703

 
End of Announcement DGAP News Service

1019703  09-Apr-2020 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1019703&application_name=news&site_id=boersengefluester_html


Die wichtigsten Finanzdaten auf einen Blick
  2016 2017 2018 2019 2020 2021 2022e
Umsatzerlöse1 2.523,84 2.572,26 2.595,01 2.780,82 3.406,78 3.328,42 3.112,00
EBITDA1,2 222,70 240,00 147,91 193,71 521,07 421,00 220,00
EBITDA-Marge3 8,82 9,33 5,70 6,97 15,30 12,65 7,07
EBIT1,4 136,91 155,74 62,65 66,58 396,60 271,68 90,00
EBIT-Marge5 5,42 6,05 2,41 2,39 11,64 8,16 2,89
Jahresüberschuss1 81,74 98,50 34,90 33,79 249,89 154,27 40,00
Netto-Marge6 3,24 3,83 1,34 1,22 7,34 4,64 1,29
Cashflow1,7 195,32 143,34 4,09 164,42 459,98 384,89 200,00
Ergebnis je Aktie8 3,40 4,12 1,42 1,38 10,19 7,13 2,10
Dividende8 0,13 0,40 0,13 0,13 0,13 0,13 0,13
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2021 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: -

INVESTOR-INFORMATIONEN
©boersengefluester.de
Drägerwerk ST
WKN Kurs in € Einschätzung Börsenwert in Mio. €
555060 43,800 Kaufen 879,31
KGV 2023e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
10,43 18,14 0,58 9,93
KBV KCV KUV EV/EBITDA
0,62 2,13 0,26 2,56
Dividende '20 in € Dividende '21e in € Div.-Rendite '21e
in %
Hauptversammlung
0,13 0,13 0,30 06.05.2022
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
28.04.2022 28.07.2022 27.10.2022 03.03.2022
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
3,51% -9,54% -19,04% -41,29%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu Drägerwerk AG & Co. KGaA  ISIN: DE0005550602 können Sie bei DGAP abrufen


Medtech , 555060 , DRW8 , XETR:DRW8